Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Active Ingredient	Dosage Form	Classification	Submission	Acceptance Date	Manufacturers	Manufacturers	Review Status	Status Date	View
CXSL1600113	重组人源化抗CD52单克隆抗体注射液	Recombinant anti-CD52 humanized monoclonal antibody	Injection	Biological Products(7)	New Drug Application	2017-05-03	兰州生物制品研究所有限责任公司	Lanzhou Institute of Biological Products Co Ltd	Certificate Issued	2018-02-27	view
CXSL0500039	重组抗CD52人源化单克隆抗体注射液	Recombinant anti-CD52 humanized monoclonal antibody	Injection	Biological Products(2)	New Drug Application	2005-05-30	上海张江生物技术有限公司	Shanghai Zhangjiang BIOTECHNOLOGY Co Ltd	Certificate Issued	2006-07-13	view
CXSL1400091	重组抗CD52人源化单克隆抗体注射液	Recombinant anti-CD52 humanized monoclonal antibody	Injection	Biological Products(2)	New Drug Application	2014-11-25	浙江海正药业股份有限公司	Zhejiang Hisun Pharmaceutical Co Ltd	Certificate Issued	2016-03-25	view